中核國際(02302.HK):聯交所附加復牌指引
中核國際(02302.HK)表示,在向聯交所提交獨立專家初步進度匯總報告後,獨立專家在報告中認為,減值是由公司內部監控缺陷等原因造成,近日收到聯交所信函,其中表示其認為以下為附加復牌指引,包括要求公司進行內部控制獨立調查,證明公司已具備充分的內部控制和相關程式,以符合上市規則規定。
中核國際表示,正採取適當措施解決導致其停牌的問題,並完全遵守上市規則,使聯交所滿意,以便在切實可行範圍內儘快恢復公司股份的交易。
應公司要求,股份已由2021年4月30日起暫停買賣,並將繼續暫停買賣直至另行通知為止。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.